QQ客服 官方微博 反馈留言

	The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system
	Yang, C.; Cheng, H.; Luo, G.; Lu, Y.; Guo, M.; Jin, K.; Wang, Z.; Yu, X.; Liu, C.
刊名	EJSO
	2017
卷号	43期号:11
关键词	Scoring system Pancreatic ductal adenocarcinoma (PDAC) Peripheral lymphocyte subsets CD4/CD8 ratio CA125 Prognosis
ISSN号	0748-7983
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3620591
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Yang, C.,Cheng, H.,Luo, G.,et al. The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system[J]. EJSO,2017,43(11).
APA	Yang, C..,Cheng, H..,Luo, G..,Lu, Y..,Guo, M..,...&Liu, C..(2017).The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system.EJSO,43(11).
MLA	Yang, C.,et al."The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system".EJSO 43.11(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。